Renal Cancers Completed Phase 0 Trials for Aldesleukin (DB00041)

Also known as: Renal Cancer / Kidney Cancer / Renal malignant neoplasm / Renal neoplasms malignant / Cancer of Kidney

IndicationStatusPhase
DBCOND0044624 (Renal Cancers)Completed0
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00278369Pilot Study of Denileukin Diftitox Plus High-Dose IL-2 for Patients With Metastatic Renal CancerTreatment
NCT00276835Genistein and Interleukin-2 in Treating Patients With Metastatic Melanoma or Kidney CancerTreatment